The necessity for the coating of perfluorodecalin-filled poly(lactide-co-glycolide) microcapsules in the presence of physiological cholate concentrations: Tetronic-908 as an exemplary polymeric surfactant

References

• Abramson N, Schur PH. The IgG subclasses of red cell antibodies and relationship to monocytes binding. Blood 1972; 40: 500–8
   PubMedGoogle Scholar
• Bauer J, Zähres M, Zellermann A, Kirsch M, Petrat F, de Groot H, Mayer C. Perfluorocarbon-filled poly(lactide-co-gylcolide) nanocapsules as artificial oxygen carriers for blood substitutes: A physico-chemical assessment. J Microencapsul 2010; 27(2)122–32
   PubMed Web of Science ®Google Scholar
• Beck LR, Pope VZ, Flowers CE, Jr, Cowsar DR, Tice TR, Lewis DH, Dunn RL, Moore AB, Gilley RM. Poly(DL-lactide-co-glycolids)/norethissterone microcapsules: An injectable biodegradable contraceptive. Biol Reprod 1983; 28: 186–95
   PubMed Web of Science ®Google Scholar
• Bergmeyer HU, Grassl M, Walter H-E. Biochemical reagents for general use. Methods of enzymatic analysis, HU Bergmeyer. Verlag Chemie, Weinheim 1983; 165
   Google Scholar
• Bottalico LA, Betensky HT, Min YB, Weinstock SB. Perfluorochemical emulsions decrease Kupffer cell phagocytosis. Hepatology 1991; 14: 169–74
   PubMed Web of Science ®Google Scholar
• Brush T, Wing E, Straub A, Mathiowitz, E, Bernstein H. 1997. Mikroverkapselte fluorierte Gase zur Anwendung als bilderzeugende Mittel. Patent Application 69729088, 27 February
   Google Scholar
• Garvin K, Feschuk C. Polylactide-polyglycolide antibiotic implants. Clin Orthop Relat Res 2005; 437: 105–10
   PubMed Web of Science ®Google Scholar
• Harris JM, Zalipsky S. Poly(ethylene glycol), chemistry and biological applications. American Chemical Society, Washington, DC 1997
   Google Scholar
• Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B, Huang X, Moore DD. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006; 312(14)233–6
   PubMedGoogle Scholar
• Ikada Y, Tabata Y. Phagocytosis of bioactive microspheres. J Bioactive Compat Polym 1986; 1(1)32–46
   Google Scholar
• Illum L, Davis SS, Muller RH, Mak E, West P. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer – poloxamine 908. Life Sci 1987; 40: 367–74
   PubMed Web of Science ®Google Scholar
• Kanke M, Simmons GH, Weiss DL, Bivins BA, de Luca PP. Clearance of 141Ce-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs. J Pharm Sci 1980; 69(7)755–62
   PubMedGoogle Scholar
• Kolb-Bachofen V, Abel F. Participation of D-galactose-specific receptors of liver macrophages in recognition of fibronectin-opsonized particles. Carbohydr Res 1991; 213: 201–13
   PubMedGoogle Scholar
• Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int J Pharm 2008; 363(1–2)26–39
   PubMed Web of Science ®Google Scholar
• Moghimi SM. Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block-copolymers. Adv Drug Delivery Rev 1995; 16: 183–93
   Web of Science ®Google Scholar
• Moghimi SM, Muir IS, Illum L, Davis SS, Kolb-Bachofen V. Coating particles with a block copolymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta 1993; 1179: 157–65
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Porter CJH, Muir IS, Illum L, Davis SS. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: Influence of particle size and hydrophilic coating. Biochem Biophys Res Commun 1991; 177(2)861–6
   PubMed Web of Science ®Google Scholar
• Newman MJ, Balusubramnian M, Todd CW. Development of adjuvant-active non-ionic block copolymers. Adv Drug Delivery Rev 1998; 32: 199–223
   PubMed Web of Science ®Google Scholar
• Patel HM. Serum opsonins and liposomes: Their interaction and opsonophagocytosis. Crit Rev Ther Drug Carrier Syst 1992; 9(1)39–90
   PubMed Web of Science ®Google Scholar
• Peters SC, Reis A, Noll T. Preparation of endothelial cells from micro - and macrovascular origin. Practical methods in cardiovascular research, S Dhein, SW Mohr, M Delmar. Springer-Verlag, Berlin 2005; 610–29
   Google Scholar
• Pisani E, Tsapis N, Paris J, Nicolas V, Cattel L, Fattal E. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir 2006; 22: 4397–402
   PubMed Web of Science ®Google Scholar
• Ratzinger G, Fillafer C, Kerleta V, Wirth M, Gabor F. The role of surface functionalization in the design of PLGA micro- and nanoparticles. Crit Rev Ther Drug Carrier Syst 2010; 27(1)1–83
   Web of Science ®Google Scholar
• Rauen U, Noll T, Piper M, Lauchart W, Becker HD, de Groot H. Endothelial cell toxicity of preservation solutions: Comparison of endothelial cells of different origin and dependence on growth state. Cryobiology 1994; 31: 144–53
   PubMedGoogle Scholar
• Reed WP. Serum factor capable of opsonizing shigella for phagocytosis by polymorphonuclear neutrophils. Immunology 1975; 28: 1051–9
   PubMedGoogle Scholar
• Rhodes J. Receptor for monomeric IgM on guinea pig splenic macrophages. Nature 1973; 243: 527–8
   PubMedGoogle Scholar
• Riess JG. Oxygen carriers (“blood substitutes”)-raison d’etre, chemistry, and some physiology. Chem Rev 2001; 101: 2797–919
   PubMed Web of Science ®Google Scholar
• Riess JG, Krafft MP. Fluorocarbon emulsions as in vivo oxygen delivery systems: Background and chemistry. Blood substitutes, RM Winslow. Academic Press/Elsevier, Amsterdam 2006; 259–75
   Google Scholar
• Rudolph G, Endele R, Senn M, Stiehl A. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis. Hepatology 1993; 17: 1028–32
   PubMed Web of Science ®Google Scholar
• Singh M, Kazzaz J, Ugozzoli M, Chesko J, O’Hagan DT. Charged polylactide co-glycolide microparticles as antigen delivery systems. Expert Opin Biol Ther 2004; 4(4)483–91
   PubMed Web of Science ®Google Scholar
• Singh M, Kazzaz J, Ugozzoli M, Malyala P, Chesko J, O’Hagan DT. Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems. Curr Drug Deliv 2006; 3(1)115–20
   PubMedGoogle Scholar
• Slack JD, Kanke M, Simmons GH, DeLuca PP. Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration. J Pharm Sci 1981; 70(6)660–4
   PubMed Web of Science ®Google Scholar
• Stolnik S, Dunn SE, Garnett MC, Davies MC, Coombes AGA, Taylor DC, Irving MP, Purkiss SC, Tadros TF, Davis SS, et al. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res 1994; 11(12)1800–8
   PubMed Web of Science ®Google Scholar
• Tabata Y, Ikada Y. Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. J Biomed Mater Res 1988; 22: 837–58
   PubMed Web of Science ®Google Scholar
• Tadros TF. Applied surfactants. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 2005
   Google Scholar
• Turrini F, Arese P, Yuan J, Low PS. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J Biol Chem 1991; 266(35)23611–7
   PubMed Web of Science ®Google Scholar
• van Furth R. Answered and unanswered questions about macrophages. Acta Paediatr Hung 1989; 29: 11–21
   Google Scholar
• Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 2008; 364(2)298–327
   PubMed Web of Science ®Google Scholar